Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells

Clinical Endocrinology

Volumn 69, Issue 3, 2008, Pages 462-470

  Malik, Minnie ^a   Webb, Joy ^a   Catherino, William H ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; CYTOCHROME P450 26A1; FIBRONECTIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; VERSICAN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; MYOMETRIUM; PHENOTYPE; SIGNAL TRANSDUCTION; TRETINOIN; UTERINE NEOPLASMS;

EID: 49649086951     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03207.x     Document Type: Article

References (45)

1. Baird, D.D. (2004) Invited commentary: uterine leiomyomata - we know so little but could learn so much. American Journal of Epidemiology, 159, 124 126.
2. Flake, G.P., Andersen, J. Dixon, D. (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environmental Health Perspectives, 111, 1037 1054.
3. Leppert, P.C., Catherino, W.H. Segars, J.H. (2006) A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. American Journal of Obstetrics and Gynecology, 195, 415 420.
4. Lotan, R. (1991) Retinoids as modulators of tumor cells invasion and metastasis. Seminars in Cancer Biology, 2, 197 208.
5. Ara, C., Devirgiliis, L.C. Massimi, M. (2004) Influence of retinoic acid on adhesion complexes in human hepatoma cells: a clue to its antiproliferative effects. Cell Communication and Adhesion, 11, 13 23.
6. Catherino, W.H. Malik, M. (2007) Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure. Fertility and Sterility, 87, 1388 1398.
7. Catherino, W.H., Leppert, P.C., Stenmark, M.H., Payson, M., Potlog-Nahari, C., Nieman, L.K. Segars, J.H. (2004) Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes, Chromosomes and Cancer, 40, 204 217.
8. Malik, M. Catherino, W.H. (2007) Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertility and Sterility, 87, 1166 1172.
9. Rhim, J.S. (2003) Generation of immortal human prostate cell lines for the study of prostate cancer. Methods in Molecular Medicine, 81, 69 77.
10. Parker, J.D., Malik, M. Catherino, W.H. (2007) Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor. Fertility and Sterility, 88, 39 46.
11. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 29, e45.
12. Zaragoza, R., Gimeno, A., Miralles, V.J., Garcia-Trevijano, E.R., Carmena, R., Garcia, C., Mata, M., Puertes, I.R., Torres, L. Vina, J.R. (2007) Retinoids induce MMP-9 expression through RARα during mammary gland remodeling. American Journal of Physiology-Endocrinology Metabolism, 292, E1140 E1148.
13. Ozpolat, B., Mehta, K., Tari, A.M. Lopez-Berestein, G. (2002) All-trans-retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. American Journal of Hematology, 70, 39 47.
14. Ozpolat, B., Mehta, K. Lopez-Berestein, G. (2005) Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells. Leukemia and Lymphoma, 46, 1497 1506.
15. Osanai, M. Petkovich, M. (2005) Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Molecular Pharmacology, 67, 1808 1817.
16. Leppert, P.C., Baginski, T., Prupas, C., Catherino, W.H., Pletcher, S. Segars, J.H. (2004) Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertility and Sterility, 82, 1182 1187.
17. Wight, T.N. (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Current Opinions in Cell Biology, 14, 617 623.
18. Westergren-Thorsson, G., Norman, M., Bjornsson, S., Endresen, U., Stjernholm, Y., Ekman, G. Malmstrom, A. (1998) Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-β in the human cervix during pregnancy and involution. Biochemica Biophysica Acta, 1406, 203 213.
19. Zimmermann, D. (2000) Versican. In : R. Iozzo, ed. Proteoglycans - Structure, Biology and Molecular Interactions. Marcel Dekker, New York, 327 341.
20. Zirn, B., Samans, B., Spangenberg, C., Graf, N., Eilers, M. Gessler. M. (2005) All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene, 24, 5246 5251.
21. Jakowlew, S.B., Zakowicz, H. Moody, T.W. (2000) Retinoic acid down-regulates VPAC (1) receptors and TGF-β3 but up-regulates TGF-β2 in lung cancer cells. Peptides, 21, 1831 1837.
22. Makhijani, N.S., Bischoff, D.S. Yamaguchi, D.T. (2005) Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-β isoforms. Journal of Cell Physiology, 202, 304 313.
23. Lee, B.S. Nowak, R.A. (2001) Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGF-β3) and altered responses to the antiproliferative effects of TGF-β. Journal of Clinical Endocrinology and Metabolism, 86, 913 920.
24. Tsibris, J.C., Segars, J., Coppola, D., Mane, S., Wilbanks, G.D., O'Brien, W.F. Spellacy, W.N. (2002) Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertility and Sterility, 78, 114 121.
25. 125I]TGF-β1-binding sites. Endocrinology, 135, 439 449.
26. Sozen, I. Arici, A. (2002) Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertility and Sterility, 78, 1 12.
27. Arici, A. Sozen, I. (2003) Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-β1 in human myometrium and leiomyoma. American Journal of Obstetrics and Gynecology, 188, 76 83.
28. Luo, X., Ding, L., Xu, J. Chegini, N. (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-β. Endocrinology, 146, 1097 1118.
29. Arici, A. Sozen, I. (2000) Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertility and Sterility, 73, 1006 1011.
30. Tsibris, J.C., Porter, K.B., Jazayeri, A., Tzimas, G., Nau, H., Huang, H., Kuparadze, K., Porter, G.W., O'Brien, W.F. Spellacy, W.N. (1999) Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor α, and all-trans retinoic acid than myometrium. Cancer Research, 59, 5737 5744.
31. Verrecchia, F. Mauviel, A. (2002) Transforming growth factor-β signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. Journal of Investigative Dermatology, 118, 211 215.
32. Bodner-Adler, B., Bodner, K., Kimberger, O., Czerwenka, K., Leodolter, S. Mayerhofer, K. (2004) Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Journal of the Society for Gynecologic Investigation, 11, 182 186.
33. Wolanska, M., Sobolewski, K., Bankowski, E. Jaworski, S. (2004) Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecologic and Obstetric Investigation, 58, 14 18.
34. Gamage, S.D., Bischoff, E.D., Burroughs, K.D., Lamph, W.W., Gottardis, M.M., Walker, C.L. Fuchs-Young, R. (2000) Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma. Journal of Pharmacology and Experimental Therapeutics, 295, 677 681.
35. Mangioni, S., Vigano, P., Lattuada, D., Abbiati, A., Vignali, M. Di Blasio, A.M. (2005) Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. Journal of Clinical Endocrinology and Metabolism, 90, 5349 5355.
36. Broaddus, R.R., Xie, S., Hsu, C.J., Wang, J., Zhang, S. Zou, C. (2004) The chemopreventive agents' 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas. American Journal of Obstetrics and Gynecology, 190, 686 692.
37. Boettger-Tong, H., Shipley, G., Hsu, C.J. Stancel, G.M. (1997) Cultured human uterine smooth muscle cells are retinoid responsive. Proceedings of the Society for Experimental Biology and Medicine, 215, 59 65.
38. Arany, I., Whitehead, W.E., Grattendick, K.J., Ember, I.A. Tyring, S.K. (2002) Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regultory factor 1 in cervical squamous carcinoma (SiHa) cells. Clinical and Diagnostic Laboratory Immunology, 9, 1102 1106.
39. Tabata, C., Kadokawa, Y., Tabata, R., Takashi, M., Okoshi, K., Sakai, Y., Mishima, M. Kubo, H. (2006) All-trans retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 174, 1352 1360.
40. Axel, D.I., Frigge, A., Dittman, J., Runge, H., Spyridopoulos, I., Riessen, R., Viebahn, R. Karsch, K.R. (2001) All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovascular Research, 49, 851 862.
41. Lee, H.Y., Sueoka, N., Hong, W.K., Mangelsdorf, D.J., Claret, F.X. Kurie, J.M. (1999) All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Molecular Cell Biology, 19, 1973 1980.
42. Alasyed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D.V., Minucci, S., Bokoch, G. Platanias, L.C. (2001) Activation of Rac1 and p38 Mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. Journal of Biological Chemistry, 276, 4012 4019.
43. Tabata, C., Kubo, H., Tabata, R., Wada, M., Sakuma, K., Ichikawa, M., Fujita, S., Mio, T. Mishima, M. (2006) All-trans retinoic acid modulates radiation-induced proliferation of fibroblasts via IL-6/IL-6R system. American Journal of Physiology - Lung Cellular and Molecular Physiology, 290, L597 L606.
44. Laping, N.J., Everitt, J.I., Frazier, K.S., Burgert, M., Portis, M.J., Cadacio, C., Gold, L.I. Walker, C.L. (2007) Tumor-specific efficacy of transforming growth factor-β RI inhibition in Eker rats. Clinical Cancer Research, 13, 3087 3099.
45. Zengli, Y. Xing, Y. (2006) All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-β/Smad signaling. Biochemistry and Biophysics Research Communications, 340, 929 934.